Pancreatic Cancer Research

ResearcherAnhui Medical UniversityNo recent work listed

Hongxia Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5215-734X; OpenAlex author ID A5053030535. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers

Papers 3

  1. Expression and prognostic significance of unique ULBPs in pancreatic cancer. Co-author DOI 10.2147/ott.s107771↗
  2. Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer. Co-author DOI 10.2147/tcrm.s96869↗
  3. KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology. Co-author DOI 10.1371/journal.pone.0044883↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiong Chen · 2 shared papers, 2016 · strength 0.17
  2. Jin-Qian Zhao · 1 shared paper, 2016 · strength 0.08
  3. Ruiwen Zhang · 1 shared paper, 2012 · strength 0.03
  4. Wei Wang · 1 shared paper, 2012 · strength 0.03
  5. Ming‐Hai Wang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.